Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  1990-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0360-3016(90)90342-HPMID 2262356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dear Editor

  1990cited by this paper
• [Neo-adjuvant chemotherapy].

  1988cited by this paper
• Chemotherapy in head and neck cancer.

  1983cited by this paper
• Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data.

  1973cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• The Impact of Primary Tumor Volume on Survival of Patients with Non-Surgically Treated Advanced-Stage Hypopharyngeal Cancer– Retrospective Study and Literature Overview

  2024cites this paper
• A COMPARATIVE PROSPECTIVE STUDY BETWEEN STANDARD AND ALTEREDFRACTIONATED RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECKSQUAMOUS CELL CARCINOMA

  2023cites this paper
• Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group.

  2021cites this paper
• Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.

  2021cites this paper
• Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

  2020cites this paper
• Altered fractionation radiotherapy with or without chemotherapy in the treatment of head and neck cancer: a network meta-analysis

  2018cites this paper
• Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.

  2018cites this paper
• Comparison of response and acute toxicities of concurrent chemoradiation with weekly cisplatin vs. paclitaxel/carboplatin in locally advanced squamous cell carcinoma of head & neck: Protocol of a short-term phase III trial

  2018cites this paper
• A network meta-analysis of the sequencing and types of systemic therapies with definitive radiotherapy in locally advanced squamous cell carcinoma of the head and neck (LASCCHN)☆.

  2017cites this paper
• Comprehensive Overview: Definitive Radiotherapy and Concurrent Chemoradiation in Locally Advanced Head and Neck Cancer

  2017cites this paper
• Chapter 34 – Nasopharyngeal Carcinoma

  2016cites this paper
• Hyperfractionated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

  2015influential citation
• Comparative Study of Gemcitabine Versus Cisplatin Concurrent with Radiotherapy for Locally Advanced Head and Neck Cancer

  2014cites this paper
• Head and Neck Cancers, Version 2.2014

  2014cites this paper
• Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology.

  2014cites this paper
• Odległe wyniki i analiza przyczyn niepowodzeń u chorych na raka krtani napromienianych konwencjonalnie i schematem przyspieszonego frakcjonowania w latach 1995–1998

  2014cites this paper
• [Long-term results and cause of failure analysis in larynx cancer patients irradiated conventionally and with accelerated fractionation schedules in 1995-1998].

  2014cites this paper
• Evaluation of Neo-Adjuvant, Concurrent and Adjuvant Chemotherapy in the Treatment of Head and Neck Squamous Cell Carcinoma: A Meta-Analysis

  2014cites this paper
• THE MET RECEPTOR TYROSINE KINASE IS A POTENTIAL THERAPEUTIC TARGET IN COMBINATION WITH RADIATION IN HEAD AND NECK SQUAMOUS CELL CARCINOMA

  2012cites this paper
• Prognostic factors in patients with advanced hypopharyngeal squamous cell carcinoma treated with concurrent chemoradiotherapy.

  2012cites this paper
• 2 Hypopharyngeal Cancer

  2012cites this paper
• Treatment outcomes of locally advanced oropharyngeal cancer: a comparison between combined modality radio-chemotherapy and two variants of single modality altered fractionation radiotherapy.

  2011cites this paper
• Head and neck cancers.

  2011cites this paper
• Head and Neck CancersPractice Guidelines in Oncology

  2011cites this paper
• Head and Neck Cancers

  2011cites this paper
• Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.

  2011cites this paper
• Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study.

  2011cites this paper
• Early Stage Nasopharyngeal Cancer: A Highly Curative Disease with Radiation Therapy

  2010cites this paper
• Hyperfractionated or accelerated radiotherapy for head and neck cancer.

  2010cites this paper
• Concomitant chemoradiotherapy using carboplatin, tegafur-uracil and leucovorin for stage III and IV head-and-neck cancer: results of GORTEC Phase II study.

  2010cites this paper
• Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapy.

  2010cites this paper
• Concomitant Cisplatin, Paclitaxel, and Hyperfractionated Radiotherapy in Locally Advanced Head and Neck Cancer: Comparison of Two Different Schedules

  2009cites this paper
• Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data.

  2009cites this paper
• Definitive Altered Fractionation Radiotherapy and Concomitant Weekly Cisplatin for Locally Advanced Head and Neck Cancer

  2009cites this paper
• Chimiothérapie des cancers de la cavité orale

  2008cites this paper
• Controversies in the management of oropharynx cancer.

  2008cites this paper
• Radiotherapy treatment delays and their influence on tumour control achieved by various fractionation schedules.

  2008cites this paper
• Increased plate and osteosynthesis related complications associated with postoperative concurrent chemoradiotherapy in oral cancer

  2008influential citation
• Current and emerging standards of concomitant chemoradiotherapy.

  2008cites this paper
• SEARCHING FOR RADIOSENSITIZERS: DEVELOPMENT OF A NOVEL ASSAY AND HIGH-THROUGHPUT SCREENING

  2008cites this paper
• [Cancer chemotherapy of the upper aerodigestive tract].

  2008cites this paper
• Management of locally advanced or unresectable head and neck cancer.

  2008cites this paper
• Radiotherapeutic management of laryngeal carcinoma.

  2008cites this paper
• The chemoradiation paradigm in head and neck cancer

  2007cites this paper
• Comparative study of efficacy and toxicities of cisplatin vs vinorelbine as radiosensitisers in locally advanced head and neck cancer

  2007cites this paper
• Combined modality treatment of laryngeal squamous cell carcinoma

  2007cites this paper
• CANCER DRUG DISCOVERY AND DEVELOPMENT

  2007influential citation
• Taxane‐based chemoirradiation for organ preservation with locally advanced head and neck cancer: Results of a phase II multi‐institutional trial

  2007cites this paper
• Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma

  2007cites this paper
• A Phase I Study of Concurrent Chemoradiotherapy with S-1 for T2N0 Glottic Carcinoma

  2007cites this paper
• Chimiothérapie des cancers de la cavité orale

  2007cites this paper
• Clinical trial design limitations in head and neck squamous cell carcinomas

  2007cites this paper
• Chemoradiation therapy: the evolving role in head and neck cancer and its application to oral cavity tumors.

  2006cites this paper
• Altered and Conventional Fractionated Radiotherapy in Locoregional Control and Survival of Patients with Squamous Cell Carcinoma of the Larynx, Oropharynx, and Hypopharynx

  2006cites this paper
• Phase II study of gemcitabine concurrent with radiation in locally advanced squamous cell carcinoma of head and neck: Trial of the Cancer Research Group Pakistan.

  2006cites this paper
• Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.

  2006cites this paper
• Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma

  2006cites this paper
• Long-Term Results of Conventional Radiotherapy versus Accelerated Hyperfractionated Radiotherapy versus Concomitant Radiotherapy and Chemotherapy in Locoregionally Advanced Carcinoma of the Oropharynx

  2006cites this paper
• Concurrent chemo-radiotherapy with mitomycin C compared with porfiromycin in squamous cell cancer of the head and neck: final results of a randomized clinical trial.

  2005cites this paper
• Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German

  2005cites this paper
• Carboplatin and tegafur-uracil concomitant with standard radiotherapy in the management of locally advanced head and neck cancer

  2005cites this paper
• Treatment of recurrent head and neck cancer: re-irradiation or chemotherapy?

  2005cites this paper
• Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer

  2005cites this paper
• Neoadjuvant and concomitant chemotherapy and radiation therapy in patients with advanced head and neck carcinoma

  2005cites this paper
• Altered Fractionation Radiotherapy in Head and Neck Cancer: Clinical Issues and Pitfalls of “Evidence-Based Medicine”

  2005cites this paper
• Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial.

  2005cites this paper
• Concurrent Chemoradiotherapy: Impact on Survival and Organ Preservation

  2005cites this paper
• Hyperfractionated Radiotherapy in Locally Advanced Nasopharyngeal Cancer

  2004cites this paper
• Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations

  2004cites this paper
• Investigation of relationship between change in locoregional control and change in overall survival in randomized controlled trials of modified radiotherapy in head-and-neck cancer.

  2004cites this paper
• The expanding role of systemic therapy in head and neck cancer.

  2004cites this paper
• [Radiotherapy of eye and orbit tumors].

  2004cites this paper
• Results of a phase I study to determine the maximum tolerated dose of capecitabine when given concurrently with radical radiotherapy in the treatment of squamous cell carcinoma of the head and neck.

  2004cites this paper
• Tumoren im Kopf- und Halsbereich

  2004cites this paper
• Radiotherapie von Augen- und Orbitatumoren

  2004cites this paper
• Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck.

  2004cites this paper
• Minimal Residual Disease in Head and Neck Cancer

  2004cites this paper
• CONCURRENT DOCETAXEL AND ACCELERATED FRACTIONATED RADIOTHERAPY FOR STAGE III AND IV HEAD AND NECK CANCERS

  2003cites this paper
• Modified fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC) & re-irradiation in recurrent head and neck carcinomas.

  2003cites this paper
• Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial.

  2003cites this paper
• Altered Fractionation and/or Adjuvant Chemotherapy in Definitive Irradiation of Squamous Cell Carcinoma of the Head and Neck

  2003influential citation
• Overview of head and neck cancer.

  2003cites this paper
• Combined Modality Strategies in the Treatment of Head and Neck Cancer

  2003cites this paper
• Radio(chemo)therapie lokal fortgeschrittener Plattenepithelkarzinome im Kopf-Hals-Bereich

  2003cites this paper
• Combined modality treatment with full-dose chemotherapy and concomitant boost radiotherapy for advanced head and neck carcinoma

  2003cites this paper
• Clinical Trials in Advanced Unresectable Head and Neck Cancer

  2003cites this paper
• An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.

  2003cites this paper
• Systemic chemotherapy for squamous cell head and neck cancer

  2003cites this paper
• Head and Neck Tumors

  2003cites this paper
• SOUâASNÉ MOÎNOSTI CHEMOTERAPIE NÁDORÒ OBLASTI HLAVY A KRKU UPDATE ON HEAD AND NECK CANCER CHEMOTHERAPY

  2003cites this paper
• Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure.

  2003influential citation
• Radiotherapy for cancer of the head and neck: altered fractionation regimens.

  2002cites this paper
• Hyperfractionated-accelerated or conventionally fractionated radiotherapy for early glottic cancer.

  2002cites this paper
• Organ preservation trials for laryngeal cancer.

  2002cites this paper
• Strahlentherapie des regionären Lymphabflusses bei malignen Tumoren des Kofs-Hals-Bereiches

  2002cites this paper
• Combined chemotherapy and radiation therapy for head and neck malignancies

  2002cites this paper
• Concomitant chemoradiation for head and neck cancer: saving lives or grays?

  2001cites this paper
• Radiotherapy combined with simultaneous chemotherapy with mitomycin-C and 5-fluorouracil for inoperable head and neck cancer.

  2001cites this paper
• Long-Term Follow-up on an Intensified Treatment Regimen for Advanced Resectable Head and Neck Squamous Cell Carcinomas

  2001cites this paper
• Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer.

  2001cites this paper